Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:00
Stirring
0:06
injections definitely have a place
0:08
in our MSK2 box. It's
0:10
not the one and only treatment
0:13
and it's definitely not the first line of
0:15
treatments. I think that's something we
0:17
bear in mind. But if we can use in the right
0:19
patient at the right timing and right diagnosis,
0:22
that is brilliant because we give
0:24
our patient a window opportunity to
0:26
rehab.
0:29
Music
0:30
Welcome to Physio Explained. In today's
0:32
episode, we're joined by Dr. Sharon Chan-Braddock.
0:35
Sharon completed her professional doctorate in physiotherapy
0:37
in 2016 and brings over
0:39
14 years of experience in postgraduate
0:42
musculoskeletal education. She is
0:44
the MSC module lead for injection
0:46
therapy and developing professional practice
0:49
with the Society of Musculoskeletal Medicine,
0:51
the SOM, and holds a distinction of being
0:53
the first physiotherapist in the UK and
0:56
internationally to achieve both SOM fellowship
0:58
and MACP membership. in
1:00
this episode we cover everything from what
1:03
corticosteroid injections aim to achieve
1:06
how effective they really are in clinical practice
1:08
And we look at the evolution and changes in practice
1:10
over the last 15 years. And then
1:13
finally, we look at patient selection and
1:15
timing, when we should consider utilising
1:18
corticosteroid injections. This is
1:20
a fascinating discussion packed with insights
1:22
for any clinician considering or
1:24
using corticosteroid injections in their practice.
1:27
I'm James Armstrong, and this is Physio
1:29
Explained. sharon
1:35
it's great to have you on the podcast today
1:38
thank you so much for joining us
1:40
Thank you for having me today. So
1:41
we're going to be talking about a really interesting topic,
1:43
particularly interesting for me as well. It's
1:45
about corticosteroid injections and we're going
1:48
to get dive straight into the up-to-date
1:50
sort of clinical reasoning, the evidence and
1:52
how we should be using them at the moment. I
1:54
thought what better way to kick this off with
1:57
what are corticosteroid injections aiming
1:59
to do and how are they aiming
2:01
to work in the body, Sharon?
2:03
So steroid injections have been used
2:05
in musculoskeletal medicine for a long time,
2:08
since 1960. So
2:10
the main properties of steroid injections
2:13
is anti-inflammatory medications,
2:15
but also has its immunosuppressive
2:18
effects. And the main indication
2:20
to use an MSK practice is to
2:22
reduce pain and inflammation,
2:24
and therefore it facilitates
2:27
that patient's rehab
2:30
and loading program. Majority
2:32
of the steroid injections will be used in
2:34
conjunction with other managements. So
2:37
it's fairly, it's used as a standalone
2:39
treatment. And therefore we always
2:41
have to think about that wrap around
2:44
care, personalized care. So
2:47
ingestions are often best used as
2:49
a total management of the plan.
2:52
So for example, if someone's pain
2:54
is the main barrier to prevent
2:56
them from rehab or pain
2:58
really disturbed their sleep or affect
3:01
their function, like their work
3:03
and their hobbies, then that
3:06
could be the indications of using
3:08
pain. steroid injections to give them a window
3:10
of opportunity to be able to engage
3:13
with rehab and physiotherapy. So
3:15
in terms of how steroids work, your buddy
3:17
is very clever. So steroids is
3:20
a liposoluble hormone and
3:22
it interacts with one of the biological
3:24
targets, which is the receptors. So
3:26
basically the receptors bind
3:29
with the glucocorticoid
3:31
receptors and it's diffused
3:34
into the cyprism and this
3:36
will trigger a number of events in the
3:38
nucleus And that's
3:41
how they create the anti-inflammatory
3:43
effects of your body. So that's
3:45
basically how it works. Wonderful.
3:47
In terms of steroid injections, obviously, we
3:50
use them around the body in different areas. Do
3:52
we know sort of how long they tend to
3:54
work for?
3:55
Yeah, that's a really good question
3:57
because our evidence is so important
4:00
to inform our practice. And part
4:02
of the important part to
4:05
give our patient informed choice or consent
4:07
is we are able to give our patients
4:09
treatment options. And that's when
4:12
we have to have the understanding about
4:14
the risks versus benefits for our patients,
4:17
understanding about the possible
4:19
risks and complications. There
4:21
is so much research out there in
4:23
corticosteroid injections, but the
4:25
general themes in terms of joint,
4:28
for example, arthritis, the
4:30
general themes is short to moderate
4:33
benefit. So it could be between a few
4:35
weeks to a few months effectiveness,
4:38
and there is no evidence to suggest
4:40
any long-term benefits. In
4:42
terms of tendinopathy, it's short-term
4:45
benefit only. We know steroids is
4:47
not the best for tendinopathy,
4:49
but that That could give some patients
4:52
a window of opportunity for them to rehab
4:54
or for that loading program. So
4:57
those are the general themes of evidence.
5:00
Obviously, we have evidence on individual
5:03
lesions that you can look into that. I
5:06
suppose with the evidence, it brings us probably really
5:08
nicely on to a topic that we were talking about
5:10
just before we started recording, and that's
5:12
how things have changed. We talked about
5:14
this. Corticosteroid injections have been used for a long
5:17
time. How have things changed over the years,
5:19
Sharon?
5:20
So I've been doing injections for 15
5:22
years. So when I trained doing steroid
5:24
injections, using local
5:26
anesthetic was a default. So
5:29
we know some risks associated with
5:31
local anesthetic. in our
5:33
central nervous system, cardiovascular system,
5:36
and allergic reactions such as anaphylactic
5:38
reactions. So we very much focus
5:40
on those. And we don't really question
5:43
why you use local anesthetic in every
5:45
single injection in those days. But
5:47
in the last 10 years, practice
5:50
has been changed because there are increasing
5:52
amount of evidence to suggest
5:55
steroids is not great for our
5:57
articular cartilage and tendons. So
5:59
we understand, we know the systemic
6:02
effects. But in terms of locally,
6:04
evidence suggests steroids
6:07
can cause chondrotoxicity.
6:09
So basically, it's toxicity
6:12
to our chondrocytes, which is cells
6:14
in articular cartilage, but also
6:17
tenotoxicity, which is toxicity
6:19
to tendon cells. And you can see
6:21
these deleterious changes very,
6:23
very similar to the natural
6:26
process of arthritis and tendinopathy.
6:29
So the question is, Do
6:31
we need to use local anesthetic
6:34
if there's not good clinical reasoning?
6:36
So the use of local anesthetic should be
6:39
used when there is, for example,
6:41
a diagnostic purpose. So you can use
6:43
local anesthetic when you want to
6:46
aid that differential diagnosis. So for
6:48
example, between cervical
6:51
reflopping and the subchromic impingement,
6:53
you want to help that differential diagnosis. or
6:55
you want to give your patients some relief, like
6:58
a pain relief, a short-term pain relief, usually
7:01
local anesthetic like the common one like
7:03
Lidocaine lasts for 90
7:05
to 120 minutes. So it's
7:08
not a short-term benefit, a
7:10
long-term benefit that you can cover
7:13
that post-injection flare, which can last
7:15
for a few days, or it doesn't
7:17
bridge that gap until the steroids work
7:19
after 24, 36 hours. So
7:22
if you are confident with your diagnosis,
7:25
and you don't need a diagnostic purpose,
7:28
then the question is, are you adding
7:30
more benefits to give your patient local
7:32
anesthetic? So the change of practices,
7:35
we become much more careful in
7:37
terms of the selection of our
7:39
use of local anesthetic. So I
7:42
think that is down to clinical reasoning,
7:45
case-by-case basis, always
7:47
thinks about that risk versus benefits
7:50
of our patients and informed choice
7:52
to our patients first. when you're utilizing
7:54
steroid injections.
7:56
This
8:00
podcast is sponsored by Cliniko. Cliniko
8:02
is a practice management software that
8:04
helps you save time. It's used
8:06
by 65,000 practitioners worldwide.
8:09
With Cliniko, you'll get everything you need
8:11
to run a successful physio practice, like
8:14
online booking tools, treatment notes, digital
8:16
forms, customizable body charts, and
8:19
much more. Physio Network members
8:21
get 90 days for free now. Signing
8:23
up takes one minute. Just visit Cliniko.com
8:26
for That's
8:33
quite important, isn't it? Because I think some individuals
8:35
may be working under a
8:37
patient group directive or things like that, but whereby the
8:41
local anaesthetic is already
8:43
mixed and that's not
8:45
necessarily giving clinical reasoning
8:47
as to whether you're using it or not then, is it? You're
8:50
taking that clinical reasoning away from the
8:52
clinician?
8:53
Yeah, and I think that is a very, very common
8:55
question people are being asked when
8:58
we're teaching. And sometimes I
9:00
think we just need to go back to our services
9:02
and ask about, can we have other options?
9:05
Because it really depends on
9:07
the patients and the lesions. I'm not saying
9:09
steroid, local anesthetic definitely
9:11
have a place. And in some cases,
9:13
we may use pre-mix. In some places, we
9:16
may use a steroids plus
9:18
local anesthetic. In some cases,
9:20
we may use steroids alone. So it really
9:22
depends on the lesions we're dealing
9:24
with, but also patient's factors as well.
9:27
Definitely. And that leads us really nicely
9:29
onto sort of when we should be using
9:31
these. We've talked already, haven't we, really about patient
9:34
selection. And I think we could probably
9:36
dive into that a little bit more now in terms of some
9:38
of the conditions and types of patients
9:41
that we know the steroid injections
9:43
are good for. And we also potentially
9:46
with the evidence emerging now on where we, when
9:48
they might now not be so much used.
9:51
Can you talk to us a bit more about that, Sharon?
9:53
Yeah. So usually steroid injections
9:56
used in joint, so such as arthritis.
9:59
So it could be degenerated, traumatic
10:02
or inflammatory arthritis. It
10:04
could be used in tendinopathy, bursitis
10:08
and some nerve entrapments such as carpal
10:10
tunnel injections. In terms of when
10:12
we're going to use it, as everything
10:14
else in MSK management, we often
10:17
adopt that step approach. So
10:19
we want to be the least invasive
10:22
to start with and self-management,
10:25
physiotherapy, exercise, medications.
10:28
If people fail to respond
10:30
to dose and pain still are
10:32
barriers for them to engage
10:34
with rehab and physiotherapy and affecting
10:37
their function, then you may consider
10:39
steroid injections can be an option.
10:42
So often it's really important
10:44
for patients to understand about
10:46
what are they having. So it's your job
10:48
to discuss the intended benefit
10:51
and risk. But also it's really
10:53
important for people to understand this is just
10:55
part of their rehab. It's not a
10:57
one-off. It's not the end of it. It's the
10:59
start of their rehab. So
11:02
the aftercare is really important. So
11:04
you give them appropriate aftercare advice.
11:07
At the moment, we're drafting a guidance
11:09
document in terms of aftercare in
11:12
injection therapy. And also think about
11:14
the rehab pen hose injections
11:17
as well. I would probably say the one-off
11:19
that you may never see a patient again, it
11:21
could be trigger finger or trigger thumb, but
11:24
the rest of everything, you often
11:27
have to thing about rehab and patients
11:29
need to engage in terms of
11:32
relatively rest for two weeks after injections
11:35
and then go back to engage with the physiotherapy
11:37
and rehab afterwards so
11:40
it's kind of agreement and a contract
11:42
with your patients that they have to understand
11:44
those to get the maximum benefits of
11:46
it.
11:47
I suppose that's where our patient education comes
11:49
in we need the patient to understand the
11:51
process and quite a lot really about what's
11:54
happening and why we're doing it to then
11:56
engage with that process don't we really?
11:58
Yeah because like I said that is when
12:01
your evidence come along like
12:03
it lasts for a few weeks to a few months but
12:06
it doesn't mean after a few months you have your
12:08
pain coming back again because if
12:10
you can give your patients some short-term
12:13
relief they will be able to go back to their
12:15
normal function they will have better
12:17
sleep they will feel happier
12:20
and they can engage with
12:22
their rehab better and all this just break
12:25
that visual circle and on
12:27
the top of other management and self-management,
12:30
then that gives them a more sustainable
12:33
effect.
12:34
Definitely. What are your thoughts around
12:37
repeat injections? Because we
12:39
might see a patient who we think, right, okay,
12:41
they're not sleeping. They're struggling to engage
12:43
with rehabilitation and actually an injection
12:45
here. They've tried our over-the-counter
12:48
medications. They've got that stepwise approach.
12:50
We're thinking, right, give them the injection. And
12:52
they get some relief. They undertake the rehab
12:55
alongside it. They do everything we're asking. But
12:57
that relief is quite short term. We know
12:59
that sometimes it can be. What
13:02
are your thoughts around repeating that injection?
13:04
That's a good question too. It could
13:07
be case by case basis. So
13:09
repeated injections
13:12
is normally not recommended. If your first
13:14
injection, it doesn't work because the
13:17
first thing you think about is, is
13:19
this the right diagnosis? So you
13:21
need to think about differentiated diagnosis. There
13:23
are also many factors. It's
13:26
not necessarily your ingestion techniques
13:28
or your diagnosis, but a lot
13:30
of other factors, patient factors. For example,
13:33
someone have a background of
13:35
chronic pain, sensitizations,
13:38
referral pain. So again,
13:41
it's go back to that diagnosis
13:43
and consider any, like, is there any other
13:46
pathologies causing it? It could be, is that
13:48
they're engaging their rehab? So
13:50
again, In terms of guidelines, for
13:53
example, NICE guidelines suggest a
13:55
weight-bearing joint should not be injected
13:57
more than four to six months. So
14:00
you really should not have more than two
14:02
or three times a year for knee injections.
14:05
So if someone comes to me, for example,
14:07
the third time of the year wanting
14:09
a steroid injection of the knee, then
14:12
I would consider whether
14:15
it's too severe that they may need to consider
14:17
surgery. Are we having a great diagnosis
14:20
here? Or is there any other
14:22
factors may causing this ongoing
14:25
pain? And sometimes it's
14:27
not just MSK issues. It's maybe
14:29
you need to think about outside the box.
14:32
People may have diabetes. Would that be
14:35
like diabetic neuropathy? Would
14:37
that be some kind of vitamin
14:40
deficiency? It's got to
14:42
be outside the box as well. Particularly
14:44
many of us now were as First
14:47
contact practitioner, which you
14:49
may see those much
14:51
more in primary care. So
14:55
repeated injections need to, again, apply
14:57
that clinical reasoning, case-by-case
14:59
basis, but also study
15:02
that patient individually.
15:04
So it's that reassess,
15:06
think again process. Is your diagnosis correct? Lots
15:09
of that clinical thinking.
15:10
Yeah. But also I need to think about a lot
15:12
like past medical history, the drug
15:15
history, the social history, consider
15:18
all of this. And also it's got to be like a personalized
15:20
care approach as well. So sometimes
15:22
when you prefer someone for rehab or physio,
15:25
but the reality is they are not
15:27
very good at doing their exercise or
15:29
following self-management advice.
15:32
So those may be the reason for failure.
15:34
It's got to be looking
15:37
at various aspects. You are almost
15:39
like a detective when someone fails
15:42
injections or fails any treatments
15:44
because there are so many variables. But
15:47
I think one key thing is we want to be safe.
15:49
So safety in terms of injections.
15:52
So think about are we doing more harm to the patients
15:55
if we give them more injections?
15:58
So always going back to that risk
16:00
versus benefit. And even I've
16:02
been doing this for such a long time now, I
16:05
often still discuss cases with my colleagues.
16:08
We always like learning and every patient is very
16:10
different. So this is how we
16:12
carry on learning and make sure we
16:14
ensure that ongoing capability for
16:17
our practice.
16:19
Absolutely. What would you say some of the takeaways,
16:21
if I was to kind of pin you down and say, what
16:23
are some of the takeaways that you'd really want the
16:25
clinicians listening to this now to take from today's
16:28
episode?
16:29
Stero injections definitely
16:31
have a place in our MSK2 box.
16:33
It's not the one and only
16:35
treatment and it's definitely not the first
16:37
line of treatments. I think that's
16:40
something we bear in mind. But if we can use
16:42
in the right patient at the right timing and
16:44
right diagnosis, that is brilliant because we
16:47
give our patient a window opportunity to
16:49
rehab. So always think about clinical
16:52
reasoning, it's risk versus
16:54
benefit assessments, familiar
16:57
yourself with your local protocols and
16:59
policies, safety,
17:01
and also aftercare as well.
17:03
Because again, injections
17:06
should be used in conjunction with other
17:08
management as a total management approach.
17:10
So that would be my... Take home message for
17:13
everybody.
17:14
Brilliant. Well, that's certainly what I think I've got from this. And it's
17:16
been really, really useful, Sharon. It's
17:18
been great. I really appreciate your time today
17:20
on the episode. We've covered loads in a short space
17:22
of time. It's gone really, really quickly. And I'm
17:25
sure it'd be really great to have you on again
17:27
to talk about maybe this in more detail and
17:29
some of the lots of other things that you do, if that's
17:31
okay with you.
17:32
Yeah, of course. No problem.
17:35
Thank you very much, Sharon. We'll see you again
17:37
soon.
17:39
Bye. Thank
17:43
you.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More